The US Food and Drug Administration (FDA) has warned users not to use Cue Health’s at-home Covid-19 tests, just one week after the agency issued a warning letter saying that Cue was not following the ...

Cue Health Inc. CEO Ayub Khattak joins Yahoo Finance Live to discuss how his company has adapeted its COVID-19 test to fit the growing demand. ZACK GUZMAN: Welcome back to Yahoo Finance Live.

Cue Health, a healthcare technology company, announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue Covid-19 Test for professional point ...

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

Fresh off a $100 million Series C funding round, molecular diagnostics startup Cue Health has more good news — it has received an Emergency Use Authorization (EUA) for its rapid, point-of-care ...

Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its ...

The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes Cue Health (Nasdaq: HLTH), a healthcare technology company, today ...

The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many are finding themselves with symptoms asking: Is it allergies or a cold? COVID? Something else? Since ...